Soluciones y reactivos de la farmacopea europea (EP) (Ph. Eur.)

Las soluciones y reactivos de la Farmacopea Europea (Ph. Eur.) garantizan que los productos farmacéuticos cumplan con los altos estándares de calidad establecidos por la Unión Europea. Estas soluciones son fundamentales para probar la pureza, potencia y calidad de los medicamentos. En CymitQuimica, ofrecemos una amplia gama de soluciones y reactivos que cumplen con la Ph. Eur., apoyando la investigación farmacéutica y los procesos de control de calidad.

20
- 50
- 100
- 200

productos por página. Hay 9316 productos en esta categoría.

Datos del producto	Pureza	Rango de precios	Entrega estimada
Brimonidine for system suitability CRS REF: 41-Y0001634	- - -	115,00 €	Mar 10 Dic 24
Abacavir for peak identification CRS REF: 41-Y0001552CAS: 188062-50-2	- - -	115,00 €	Mar 10 Dic 24
Cefixime CRS REF: 41-C0684000CAS: 125110-14-7	- - -	115,00 €	Mar 10 Dic 24
Sodium hyaluronate - reference spectrum REF: 41-S0781000	- - -	115,00 €	Mar 10 Dic 24
Triamcinolone impurity C CRS REF: 41-Y0000050	- - -	115,00 €	Mar 10 Dic 24
Loratadine impurity H CRS REF: 41-Y0000605CAS: 29976-53-2	- - -	115,00 €	Mar 10 Dic 24
Carbimazole CRS REF: 41-C0465000CAS: 22232-54-8	- - -	115,00 €	Mar 10 Dic 24
Bromocriptine mesilate for system suitability CRS REF: 41-Y0000677CAS: 22260-51-1	- - -	115,00 €	Mar 10 Dic 24
DL-lysine acetylsalicylate impurity G CRS REF: 41-Y0002213CAS: 35436-74-9	- - -	115,00 €	Mar 10 Dic 24
Olmesartan medoxomil for system suitability CRS REF: 41-Y0001424CAS: 144689-63-4	- - -	115,00 €	Mar 10 Dic 24
Fenofibrate impurity G CRS REF: 41-F0048035CAS: 217636-48-1	- - -	115,00 €	Mar 10 Dic 24
Ranitidine impurity J CRS REF: 41-Y0000416	- - -	115,00 €	Mar 10 Dic 24
Zolmitriptan for system suitability CRS REF: 41-Y0001991	- - -	115,00 €	Mar 10 Dic 24
Tetracosactide CRS REF: 41-T0550000	- - -	115,00 €	Mar 10 Dic 24
Chlorhexidine dihydrochloride CRS REF: 41-C1540000CAS: 3697-42-5	- - -	115,00 €	Mar 10 Dic 24
Orbifloxacin impurity mixture CRS REF: 41-Y0001147CAS: 113617-63-3	- - -	115,00 €	Mar 10 Dic 24
Leflunomide for peak identification CRS REF: 41-Y0000674CAS: 75706-12-6	- - -	115,00 €	Mar 10 Dic 24
Cyclizine hydrochloride CRS REF: 41-C3090000CAS: 303-25-3	- - -	115,00 €	Mar 10 Dic 24
Fluoxetine impurity C CRS REF: 41-F0253030CAS: 79088-29-2	- - -	115,00 €	Mar 10 Dic 24
Captopril impurity J CRS REF: 41-Y0001450CAS: 64838-55-7	- - -	115,00 €	Mar 10 Dic 24

Soluciones y reactivos de la farmacopea europea (EP) (Ph. Eur.)

Brimonidine for system suitability CRS

Ref: 41-Y0001634

Abacavir for peak identification CRS

Ref: 41-Y0001552

Cefixime CRS

Ref: 41-C0684000

Sodium hyaluronate - reference spectrum

Ref: 41-S0781000

Triamcinolone impurity C CRS

Ref: 41-Y0000050

Loratadine impurity H CRS

Ref: 41-Y0000605

Carbimazole CRS

Ref: 41-C0465000

Bromocriptine mesilate for system suitability CRS

Ref: 41-Y0000677

DL-lysine acetylsalicylate impurity G CRS

Ref: 41-Y0002213

Olmesartan medoxomil for system suitability CRS

Ref: 41-Y0001424

Fenofibrate impurity G CRS

Ref: 41-F0048035

Ranitidine impurity J CRS

Ref: 41-Y0000416

Zolmitriptan for system suitability CRS

Ref: 41-Y0001991

Tetracosactide CRS

Ref: 41-T0550000

Chlorhexidine dihydrochloride CRS

Ref: 41-C1540000

Orbifloxacin impurity mixture CRS

Ref: 41-Y0001147

Leflunomide for peak identification CRS

Ref: 41-Y0000674

Cyclizine hydrochloride CRS

Ref: 41-C3090000

Fluoxetine impurity C CRS

Ref: 41-F0253030

Captopril impurity J CRS

Ref: 41-Y0001450